Recent progress in xenotransplantation and its application to pediatric kidney disease

Area of Science:

• Nephrology
• Transplantation Immunology
• Xenobiology

Background:

• Kidney failure necessitates dialysis or transplantation, but organ shortages limit access to transplants.
• Xenotransplantation, using animal organs, is a potential solution to the global donor organ deficit.
• Advances in gene editing and immunosuppression have reduced hyperacute rejection in xenotransplantation.

Purpose of the Study:

• To explore xenotransplantation as a viable kidney replacement therapy for adult, pediatric, and fetal patients.
• To investigate the potential of fetal pig kidney transplantation, particularly for pediatric and obstetric applications.
• To address the immunological challenges and therapeutic benefits of using fetal pig kidneys.

Main Methods:

• Review of historical xenotransplantation challenges and recent breakthroughs.
• Analysis of clinical advancements, including gene-edited pig kidney transplants in living patients.
• Focus on research applying fetal pig kidney xenotransplantation, including nonhuman primate studies for Potter syndrome.

Main Results:

• Gene editing and novel immunosuppressants have significantly decreased rejection rates in xenotransplantation.
• Successful clinical studies and the first gene-edited pig kidney transplant into a living patient have been reported.
• Fetal pig kidneys show potential advantages, including reduced rejection and avoidance of vascular anastomosis.

Conclusions:

• Xenotransplantation, especially using gene-edited organs, is emerging as a critical solution for kidney failure.
• Fetal pig kidney xenotransplantation presents a novel therapeutic avenue for pediatric conditions like Potter syndrome.
• Continued research and clinical trials are essential to establish xenotransplantation as a standard treatment option.